| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 164.1 | 111.7 | 136.4 |
| Other income | 15.4 | 14.8 | 12.6 |
| Total income | 179.6 | 126.5 | 148.9 |
| Profit before exceptional items & tax | 95.6 | 45.0 | 76.9 |
| Profit before tax | 95.6 | 45.0 | 76.9 |
| Net profit | 72.4 | 33.0 | 57.2 |
| Operating margin | 53.2% | 35.6% | 51.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +26.60% |
|---|---|
| Net profit, quarter on quarter | +119.40% |
| Revenue, year on year | +20.30% |
NSE results filing, NSE: CARERATING. Figures extracted from the filing.
CARE Ratings Ltd: key numbers
- Share price
- ₹1,613.20
- Market cap
- ₹4,861 Cr
- Revenue (annual)
- ₹473.1 Cr
- Net profit (annual)
- ₹171.2 Cr
- P/E (TTM)
- 27.4×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 23.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CARE Ratings Ltd
All →CARE Ratings Management Change
CARE Ratings Limited appointed Mr. Jatindar Pal Singh Bajaj as a Non-Executive Non-Independent Director, effective October 29, 2026.
CARE Ratings Dividend
CARE Ratings Limited declared an interim dividend of ₹10 per equity share for the financial year 2026-2027. The record date is set for November 6, 2026.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
CARE Ratings Merger & Restructuring
CARE Ratings executed SPAs to sell 9.90% stakes each in subsidiary CareEdge Global IFSC to SBI and NSE IFSC. CARE will retain 80.20% post-closing.
CARE Ratings Other Announcement
CARE Ratings Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
CARE Ratings Board Meeting Date
CARE Ratings Limited intimated a board meeting scheduled for 29 October 2026 to consider unaudited half-yearly financial results and an interim dividend. No figures or decisions have been made yet.